Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 335

Research in Otolaryngology (ARO) Conference

Posted by fidest press agency su venerdì, 8 febbraio 2019

Decibel Therapeutics will showcase capabilities across its inner ear-focused drug discovery and development platform at the 42nd annual mid-winter meeting of the Association for Research in Otolaryngology (ARO) from February 9-13, 2019. The data to be presented will demonstrate new insights on the delivery of medicines to the inner ear through multiple modalities, including gene therapy and biologics, as well as the development of biomarkers, assays and tools to address cochlear synaptopathy and other disorders.“This last year has been transformative for Decibel,” said Michael Su, Ph.D., Decibel’s chief scientific officer. “Not only have we advanced two compounds for the prevention of hearing loss into Phase I clinical studies, but we’ve also strengthened our discovery and delivery capabilities in support of our early stage pipeline programs in monogenic hearing loss, tinnitus and balance. We’re looking forward to sharing this broader suite of capabilities with our colleagues at ARO.”


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: